TREA

88751602 - IMMUVANCE

Follow

Information

  • Trademark
  • 88751602
  • Serial Number
    88751602
  • Filing Date
    January 08, 2020
    5 years ago
  • Transaction Date
    July 04, 2022
    2 years ago
  • Status Date
    June 10, 2022
    2 years ago
  • Published for Opposition Date
    July 28, 2020
    4 years ago
  • Location Date
    September 22, 2020
    4 years ago
  • Status Code
    605
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    OWCZARSKI, KAREN ESTIL
  • Attorney Docket Number
    230042.204
    Attorney Name
    Jared M. Barrett
    Law Office Assigned Location Code
    O20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
IMMUVANCE
Case File Statements
  • GS0051: therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
  • GS0441: providing a website featuring medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the forgoing excluding information directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting
  • GS0421: scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the foregoing excluding medical research and scientific research consulting services directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting
Case File Event Statements
  • 6/10/2022 - 2 years ago
    33 - ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION Type: MAB5
  • 6/10/2022 - 2 years ago
    32 - ABANDONMENT - AFTER PUBLICATION Type: ABN5
  • 6/9/2022 - 2 years ago
    31 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 3/24/2022 - 2 years ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/22/2022 - 2 years ago
    29 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 3/22/2022 - 2 years ago
    28 - SOU EXTENSION 3 FILED Type: EXT3
  • 3/22/2022 - 2 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/14/2021 - 3 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/12/2021 - 3 years ago
    25 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 8/12/2021 - 3 years ago
    24 - SOU EXTENSION 2 FILED Type: EXT2
  • 8/12/2021 - 3 years ago
    23 - TEAS EXTENSION RECEIVED Type: EEXT
  • 3/19/2021 - 3 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/17/2021 - 3 years ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/17/2021 - 3 years ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 3/17/2021 - 3 years ago
    19 - TEAS EXTENSION RECEIVED Type: EEXT
  • 9/22/2020 - 4 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/28/2020 - 4 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/28/2020 - 4 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/8/2020 - 4 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/24/2020 - 4 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/24/2020 - 4 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/24/2020 - 4 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/24/2020 - 4 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/24/2020 - 4 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/23/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/22/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/22/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/27/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/27/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/27/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/13/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/11/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP